Literature DB >> 18753466

8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents.

Mario Barreto1, Maria Pia Villa2, Carla Olita2, Susy Martella2, Giovanni Ciabattoni3, Paolo Montuschi4.   

Abstract

BACKGROUND: Exercise-induced bronchoconstriction (EIB) in the asthmatic child is associated with persistent airway inflammation and poor disease control. EIB could arise partly from airway oxidative stress. Exhaled breath condensate (EBC) levels of 8-isoprostane (IsoP), which is a known marker of oxidative stress, might therefore be helpful for monitoring asthma noninvasively.
METHODS: We recruited 46 asthmatic children and adolescents 6 to 17 years of age (29 boys), all of whom underwent lung function testing, measurement of the fractional concentration of exhaled nitric oxide (FENO), and collection of EBCs for 8-IsoP measurement before and after exercise challenge. FENO was measured before exercise and 5 min and 20 min after exercise. Spirometry was repeated 1, 5, 10, 15, and 20 min after exercise.
RESULTS: Baseline 8-IsoP levels (but not baseline FENO levels) correlated with the fall in FEV(1) 5 min after exercise (r = - 0.47; p = 0.002). 8-IsoP levels measured after exercise remained unchanged from baseline levels; conversely, FENO levels decreased in parallel with the decline in FEV(1) at 5 min (r = 0.44; p = 0.002). The mean baseline 8-IsoP concentrations were higher in patients with EIB (n = 12) than in those without EIB (n = 34; 44.9 pg/mL [95% confidence interval (CI), 38.3 to 51.5] vs 32.3 pg/mL [95% CI, 27.6 to 37.0], respectively; p < 0.01). No difference was found in the mean baseline FENO between groups (with EIB group: 38.7 ppb; 95% CI, 24.5 to 61.1; without EIB group: 29.1 ppb; 95% CI, 22.0 to 38.4).
CONCLUSIONS: Increased 8-IsoP concentrations in EBC samples of asthmatic children and adolescents with EIB suggest a role for oxidative stress in bronchial hyperreactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753466     DOI: 10.1378/chest.08-0722

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

Review 1.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 2.  Pathophysiology of bronchoconstriction: role of oxidatively damaged DNA repair.

Authors:  Attila Bacsi; Lang Pan; Xueqing Ba; Istvan Boldogh
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-02

3.  Oxidative Stress in the Lung - The Essential Paradox.

Authors:  Lynette K Rogers; Mary J Cismowski
Journal:  Curr Opin Toxicol       Date:  2017-09-19

4.  Inflammatory and oxidative stress responses of healthy young adults to changes in air quality during the Beijing Olympics.

Authors:  Wei Huang; Guangfa Wang; Shou-En Lu; Howard Kipen; Yuedan Wang; Min Hu; Weiwei Lin; David Rich; Pamela Ohman-Strickland; Scott R Diehl; Ping Zhu; Jian Tong; Jicheng Gong; Tong Zhu; Junfeng Zhang
Journal:  Am J Respir Crit Care Med       Date:  2012-08-30       Impact factor: 21.405

5.  Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus.

Authors:  Rashed A Hasan; Edmund OʼBrien; Peter Mancuso
Journal:  Pediatr Crit Care Med       Date:  2012-03       Impact factor: 3.624

Review 6.  Role of cells and mediators in exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; William A Altemeier; Moira L Aitken; William R Henderson
Journal:  Immunol Allergy Clin North Am       Date:  2013-03-29       Impact factor: 3.479

Review 7.  New insights into pathogenesis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-02

Review 8.  Isoprostanes and asthma.

Authors:  Judith A Voynow; Apparao Kummarapurugu
Journal:  Biochim Biophys Acta       Date:  2011-05-08

9.  The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

Authors:  Rodney D Britt; Markus Velten; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 10.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.